Exclusive agreement for CareFusion to market SurFlash® catheters in U.S.


#IVTEAM #Intravenous products: CareFusion report “CareFusion, a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today announced an exclusive, eight-year agreement for CareFusion to co-brand, market and distribute Terumo’s SurFlash® line of safety peripheral IV catheters for the acute care segment across the United States.

The agreement includes both SurFlash and SurFlash Plus Safety IV Catheters, which are proven to improve the success of catheter placement on the first attempt by an average of 20 percent. The higher success rate for first placement can potentially enhance the patient experience, reduce wasted catheters and save clinician time, all of which reduce costs for the hospital.”

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page


Comments are closed.